Orion Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Orion Capital Management's PFE Position: Q2 2026 in Review
Orion Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 150 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #451.
Orion Capital Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $655K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Orion Capital Management held 150 shares of Pfizer worth $3.61K as of Q2 2026.
- Orion Capital Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #451 holding.
- Orion Capital Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Orion Capital Management's Pfizer position peaked at $655K in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.